A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

MedImmune LLC

ClinicalTrials.gov Identifier:

NCT01577745

First received: April 5, 2012

Last updated: May 6, 2013

Last verified: May 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2015
Estimated Primary Completion Date:	October 2014 (Final data collection date for primary outcome measure)